Edwards Lifesciences Corporation stock is up 7.12% since 30 days ago. The next earnings date is Jan 30, 2024. The company has had above-average volume in the last 30 days. Its seasonality going into this month shows a chance of a green month, as 62.5% of the previous 23 December’s closed higher than November. In the last 10 Unusual Options Trades, there were 7 CALLs, 3 PUTs. 50% of analysts rate it a buy.
Date & Time | Expiration Date | Strike Price | Trade Type | Size | Open Interest |
---|---|---|---|---|---|
24 Nov 14:59 | 17 Jan, 2025 | 55.00 | 13 | ||
27 Nov 14:48 | 17 May, 2024 | 67.50 | 147 | ||
27 Nov 15:03 | 17 Jan, 2025 | 75.00 | 74 | ||
29 Nov 15:15 | 17 Jan, 2025 | 35.00 | 64 | ||
29 Nov 19:44 | 19 Jan, 2024 | 85.00 | 787 | ||
04 Dec 16:45 | 19 Jan, 2024 | 62.50 | 2467 | ||
06 Dec 20:18 | 19 Jan, 2024 | 75.00 | 407 | ||
07 Dec 15:14 | 19 Jan, 2024 | 72.50 | 1040 | ||
08 Dec 14:47 | 17 May, 2024 | 62.50 | 79 | ||
08 Dec 20:33 | 21 Jun, 2024 | 70.00 | 262 |
Edwards Lifesciences Corporation provides products and technologies for structural heart disease, critical care and surgical monitoring. It offers surgical structural heart solutions, such as aortic surgical valve under the INSPIRIS name. The company distributes its products through a direct sales force and independent distributors.